Evidence check: CYP2C19 in the context of Abnehmen

CYP2C19 is a cytochrome P450 enzyme primarily involved in the metabolism of drugs such as clopidogrel, proton pump inhibitors, and some antidepressants. Its role in weight loss (Abnehmen) is indirect and not well-established. Some genetic studies have explored associations between CYP2C19 variants and body mass index (BMI) or response to weight loss interventions, but findings are inconsistent and effect sizes are small. For example, certain variants may influence drug metabolism that could affect appetite or energy balance, but this is speculative. Consumer DNA tests like MyBody-X may report CYP2C19 variants, but these are not validated for weight management. The primary drivers of weight loss are caloric intake, physical activity, and behavioral factors. Therefore, relying on CYP2C19 genetics for weight loss advice is not evidence-based. If you have concerns about drug metabolism (e.g., for medications), consult a healthcare provider. Evidence level: gwas/unclear.